Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Vasomax phentolamine mesylate: Update

However, ZONA said the FDA upgraded the company's IND for Vasomax to a partial clinical hold

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE